These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12494449)

  • 41. The role of the IGF system in cancer growth and metastasis: overview and recent insights.
    Samani AA; Yakar S; LeRoith D; Brodt P
    Endocr Rev; 2007 Feb; 28(1):20-47. PubMed ID: 16931767
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IGF-IR in neuroprotection and brain tumors.
    Gualco E; Wang JY; Del Valle L; Urbanska K; Peruzzi F; Khalili K; Amini S; Reiss K
    Front Biosci (Landmark Ed); 2009 Jan; 14(1):352-75. PubMed ID: 19273072
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Data on the putative role of p53 in breast cancer cell adhesion: Technical information for adhesion assay.
    Voudouri K; Nikitovic D; Berdiaki A; Tsiaoussis J; Kletsas D; Karamanos NK; Tzanakakis GN
    Data Brief; 2016 Dec; 9():568-572. PubMed ID: 27752527
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intercellular adhesions as determinants of tissue assembly and malignant invasion.
    Steinberg MS; Foty RA
    J Cell Physiol; 1997 Nov; 173(2):135-9. PubMed ID: 9365511
    [No Abstract]   [Full Text] [Related]  

  • 45. Cell attachment: what is behind the word?
    Shabana AH
    Microsc Res Tech; 1998 Nov; 43(3):205-6. PubMed ID: 9840797
    [No Abstract]   [Full Text] [Related]  

  • 46. The cell surface in development and cancer.
    Dev Biol (N Y 1985); 1986; 3():1-357. PubMed ID: 3270543
    [No Abstract]   [Full Text] [Related]  

  • 47. The IGF-I receptor and cancer.
    Baserga R; Resnicoff M; Dews M
    Endocrine; 1997 Aug; 7(1):99-102. PubMed ID: 9449042
    [No Abstract]   [Full Text] [Related]  

  • 48. Cadherins in potential link between atherosclerosis and cancer.
    Hashimoto K; Kataoka N; Mohri S; Kajiya F
    Int J Cardiol; 2011 Jun; 149(3):397. PubMed ID: 21463905
    [No Abstract]   [Full Text] [Related]  

  • 49. [Fusion of tumor with host cells in vivo].
    Lanir N; Ber R
    Harefuah; 1984 Jun; 106(12):574-6. PubMed ID: 6479729
    [No Abstract]   [Full Text] [Related]  

  • 50. Aspects of cell regulation.
    Int Rev Cytol Suppl; 1983; 15():1-283. PubMed ID: 6574121
    [No Abstract]   [Full Text] [Related]  

  • 51. Cell adhesion signaling and its impact on tumorigenesis.
    Andl CD; Al Moustafa AE; Deramaudt TB; O'Neill GM
    J Oncol; 2010; 2010():257809. PubMed ID: 21274443
    [No Abstract]   [Full Text] [Related]  

  • 52. Hypoglycemic agents and incidence of pancreatic cancer in diabetic patients: a meta-analysis.
    Zhao Z; He X; Sun Y
    Front Pharmacol; 2023; 14():1193610. PubMed ID: 37497113
    [No Abstract]   [Full Text] [Related]  

  • 53. Cannabidiol Antiproliferative Effect in Triple-Negative Breast Cancer MDA-MB-231 Cells Is Modulated by Its Physical State and by IGF-1.
    D'Aloia A; Ceriani M; Tisi R; Stucchi S; Sacco E; Costa B
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Type 1 Insulin-Like Growth Factor Receptor Nuclear Localization in High-Grade Glioma Cells Enhances Motility, Metabolism, and
    Martin A; Fernandez MC; Cattaneo ER; Schuster CD; Venara M; Clément F; Berenstein A; Lombardi MG; Bergadá I; Gutierrez M; Martí MA; Gonzalez-Baro MR; Pennisi PA
    Front Endocrinol (Lausanne); 2022; 13():849279. PubMed ID: 35574033
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolic Syndrome and Breast Cancer: Prevalence, Treatment Response, and Prognosis.
    Dong S; Wang Z; Shen K; Chen X
    Front Oncol; 2021; 11():629666. PubMed ID: 33842335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insights from the clinical phenotype of subjects with Laron syndrome in Ecuador.
    Guevara-Aguirre J; Bautista C; Torres C; Peña G; Guevara C; Palacios C; Guevara A; Gavilanes AWD
    Rev Endocr Metab Disord; 2021 Mar; 22(1):59-70. PubMed ID: 33047268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The IGF/Insulin-IGFBP Axis in Corneal Development, Wound Healing, and Disease.
    Stuard WL; Titone R; Robertson DM
    Front Endocrinol (Lausanne); 2020; 11():24. PubMed ID: 32194500
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of the Large and Small T-Antigens of Human Polyomaviruses on Signaling Pathways.
    Moens U; Macdonald A
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31408949
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loss of E-cadherin Enhances IGF1-IGF1R Pathway Activation and Sensitizes Breast Cancers to Anti-IGF1R/InsR Inhibitors.
    Nagle AM; Levine KM; Tasdemir N; Scott JA; Burlbaugh K; Kehm J; Katz TA; Boone DN; Jacobsen BM; Atkinson JM; Oesterreich S; Lee AV
    Clin Cancer Res; 2018 Oct; 24(20):5165-5177. PubMed ID: 29941485
    [No Abstract]   [Full Text] [Related]  

  • 60. Long-term exposure to carcinoma-associated fibroblasts makes breast cancer cells addictive to integrin β1.
    Dittmer A; Dittmer J
    Oncotarget; 2018 Apr; 9(31):22079-22094. PubMed ID: 29774124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.